UK approves Regeneron/Roche antibody cocktail for COVID-19
The Peninsula
The UK drug regulator has approved an antibody cocktail developed by Regeneron and Roche to prevent and treat COVID-19, it said on Friday, as the nation battles rising hospitalisations due to the more infectious Delta variant.
The Medicines and Healthcare products Regulatory Agency (MHRA) said clinical trial data shows the drug Ronapreve could help prevent infection, help resolve symptoms of severe COVID-19 infection and reduce the chances of hospitalisation. "This treatment will be a significant addition to our armoury to tackle COVID-19," British health minister Sajid Javid said in a statement.More Related News